Researchers used a standardized heart health score that combines four key measurements—blood pressure, body weight, cholesterol, and blood sugar—to assess how well teens with fatty liver disease are doing overall.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether the Life’s Essential 8 score is a valid and reliable predictor of future cardiovascular events in adolescents with MASLD compared to other metrics.
A systematic review and meta-analysis of longitudinal studies evaluating whether LE8 scores in adolescents with MASLD predict incident cardiovascular events over 10+ years, compared to alternative composite scores.
Whether LE8 scores in adolescents with MASLD track consistently over time and respond predictably to interventions.
A prospective cohort of 200 adolescents with MASLD measured for LE8 score at baseline, 6 months, and 2 years, with analysis of intra-class correlation coefficients and responsiveness to known interventions (e.g., weight loss).
Whether LE8 scores correlate with other established cardiovascular risk markers in adolescents with MASLD.
A cross-sectional study of 150 adolescents with MASLD measuring LE8 score alongside direct measures of arterial stiffness, insulin resistance, and inflammation markers to assess convergent validity.
Examples of how LE8 scores change in individual adolescents with MASLD undergoing dietary or lifestyle interventions.
A case series of 10 adolescents with MASLD documenting LE8 score changes before and after a 12-week intervention, with detailed dietary and clinical notes.
Expert consensus on whether LE8 is the most appropriate tool for assessing CVH in adolescents with MASLD.
A Delphi consensus process among 20 pediatric cardiologists and hepatologists to rate the suitability of LE8 for MASLD populations compared to alternatives.